← Leaderboards
James C Yao
University Of Tx Md Anderson Can Ctr
$2,907,879
Attributed
$4,352,606
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,269,075 · 7
By mechanism
UM1$21,083,559 · 2
U01$1,188,850 · 1
P50$996,666 · 4
Top collaborators
- Funda Meric-Bernstam16 shared
- S Gail Eckhardt12 shared
- Vicki Suzanne Klimberg4 shared
- John Sarantopoulos4 shared
- Anna Capasso3 shared
- Thomas W Flaig1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- John V. Heymach$11,138,593
- Lauren Averett Byers$9,117,683
- Faye Johnson$4,125,981
- Di Zhao$3,648,377
- Sang Taek Kim$862,948
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelUniversity Of Texas M D Anderson Cancer CenterLeadershipClinical ResearchInstitutionClinically RelevantFacultySpecimenMentorsResourcesPublicationsMeetingsPositioning AttributeClinical TrialsInnovationEvaluationTissuesNew AgentsMalignant NeoplasmsTumorDoseMolecularDesignImage
Grant awards (28)
Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,679,285
UM1 · FY2025 · CA
Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,679,285
UM1 · FY2024 · CA
Texas EXperimental Cancer Therapeutics Network - TEX CTN$1,952,013
UM1 · FY2023 · CA
Career Enhancement Program$93,608
P50 · FY2023 · CA · contact PI
Developmental Research Program$93,608
P50 · FY2023 · CA · contact PI
Developmental Research Program$93,607
P50 · FY2022 · CA · contact PI
Career Enhancement Program$93,607
P50 · FY2022 · CA · contact PI
Career Enhancement Program$171,613
P50 · FY2021 · CA · contact PI
Developmental Research Program$93,609
P50 · FY2021 · CA · contact PI
Texas EXperimental Cancer Therapeutics Network - TEX CTN$5,697,447
UM1 · FY2020 · CA
Career Enhancement Program$84,897
P50 · FY2020 · CA · contact PI
Developmental Research Program$84,897
P50 · FY2020 · CA · contact PI
Southwest Early Clinical Trials Consortium$1,029,321
UM1 · FY2019 · CA
Southwest Early Clinical Trials Consortium$320,000
UM1 · FY2019 · CA
Southwest Early Clinical Trials Consortium$120,746
UM1 · FY2019 · CA
Career Enhancement Program$93,610
P50 · FY2019 · CA · contact PI
Developmental Research Program$93,610
P50 · FY2019 · CA · contact PI
Admin-Core-001$2,167,090
UM1 · FY2018 · CA
Southwest Early Clinical Trials Consortium$2,167,090
UM1 · FY2018 · CA
Southwest Early Clinical Trials Consortium$300,000
UM1 · FY2017 · CA
Southwest Early Clinical Trials Consortium$148,709
UM1 · FY2017 · CA
Southwest Early Clinical Trials - Phase 2 Consortium$759,923
UM1 · FY2016 · CA
Southwest Early Clinical Trials Consortium$749,998
UM1 · FY2016 · CA
Southwest Early Clinical Trials Consortium$443,704
UM1 · FY2016 · CA
Southwest Early Clinical Trials Consortium$918,950
UM1 · FY2015 · CA
Southwest Early Clinical Trials Consortium$949,998
UM1 · FY2014 · CA
Phase I Studies of Targeted Anti-Cancer Therapies$594,425
U01 · FY2013 · CA · contact PI
Phase I Studies of Targeted Anti-Cancer Therapies$594,425
U01 · FY2012 · CA · contact PI